Please login to the form below

Not currently logged in
Email:
Password:

Elan

This page shows the latest Elan news and features for those working in and with pharma, biotech and healthcare.

Teva planning fresh offer for Mylan, say sources

Teva planning fresh offer for Mylan, say sources

Perrigo meanwhile is in the midst of its own buying spree having bought Belgium's Omega Pharma last November and Elan in 2013 and has just been linked to a possible

Latest news

More from news
Approximately 12 fully matching, plus 121 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    The largest of these was Perrigo's divestment to Royalty Pharma of its royalty stream from Biogen's global sales of Tysabri (natalizumab), the multiple sclerosis antibody originally developed by Elan,

  • Pharma deals during November 2014 Pharma deals during November 2014

    This follows Perrigo's acquisition of Elan in July last year for $8.6bn.

  • Pharma deals during September 2014 Pharma deals during September 2014

    2011. Alkermes. Elan. Ireland. 2012. Jazz. Azur. Ireland. 2013. Liberty Global. ... Virgin Media. UK. 2013. Actavis. Warner Chilcott. Ireland. 2013. Perrigo. Elan.

  • Pharma deals during July 2014 Pharma deals during July 2014

    In the last three days of July 2013, nine deals were announced with a total value of just over $12bn, of which Irish-based Elan's $8.6bn acquisition by Perrigo ... This time it is AbbVie's acquisition of Shire, albeit for a much bigger price tag than Elan

  • Pharma deals during March 2014 Pharma deals during March 2014

    This follows on from several other acquisitions of Irish entities, which result in US companies paying Irish corporation tax, eg the acquisition by Perrigo of Elan and Actavis' acquisition of Warner

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics